Want to join the conversation?
$MAT 2Q15 Call: On commodities & labor fees, MAT is seeing lower resin cost on commodities, but seeing other input costs outside resins, being impacted as a challenge. The direct labor cost is going up double digits and that’s why MAT is very focused on systemic cost savings initiatives to try to take direct labor out and it is progressing on that.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.